HTT and Huntington disease: In the same way, the transcriptional activation of CRYAB/HSPB5, induced by the inhibition of the glutaminyl cyclase (QPCT) enzyme, affect mutant huntingtin aggregation and toxicity and rescue the HD phenotype (Jimenez-Sanchez et al., 2015).